Paper6745127
Aspirin in the prevention of myocardial infarction. Current status.
Elwood PC. Drugs, 1984. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Aspirin in the prevention of myocardial infarction. Current status. Papers, record 6745127. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6745127
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspirin | Major topic |
| Myocardial Infarction | Major topic |
| Angina Pectoris | |
| Cerebrovascular Disorders | |
| Fibrinolytic Agents | |
| Humans | |
| Recurrence |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,268,306 | Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis. | Am Heart J | 1973 | https://conductscience.org/library/papers/4268306 | PubMed |
| 2 | 350,335 | Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. | Br Med Bull | 1978 | https://conductscience.org/library/papers/350335 | PubMed |
| 3 | 5,416,902 | Platelet function studies in human beings receiving 300 mg. of aspirin per day. | J Lab Clin Med | 1970 | https://conductscience.org/library/papers/5416902 | PubMed |
| 4 | 351,394 | A randomized trial of aspirin and sulfinpyrazone in threatened stroke. | N Engl J Med | 1978 | https://conductscience.org/library/papers/351394 | PubMed |
| 5 | 7,412,821 | Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7412821 | PubMed |
| 6 | 4,415,103 | Platelet aggregates and mural microthrombi in the early stages of acute, fatal coronary disease. | Thromb Res | 1974 | https://conductscience.org/library/papers/4415103 | PubMed |
| 7 | 630,676 | Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion. | Circulation | 1978 | https://conductscience.org/library/papers/630676 | PubMed |
| 8 | 6,103,990 | Aspirin after myocardial infarction. | Lancet | 1980 | https://conductscience.org/library/papers/6103990 | PubMed |
| 9 | 6,992,594 | The prostanoids in hemostasis and thrombosis: a review. | Am J Pathol | 1980 | https://conductscience.org/library/papers/6992594 | PubMed |
| 10 | 392,079 | A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction. | J R Coll Gen Pract | 1979 | https://conductscience.org/library/papers/392079 | PubMed |
| 11 | 6,780,093 | Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6780093 | PubMed |
| 12 | 6,345,461 | Aspirin in coronary heart disease. Comparison of six clinical trials. | Isr J Med Sci | 1983 | https://conductscience.org/library/papers/6345461 | PubMed |
| 13 | 92,668 | Aspirin and secondary mortality after myocardial infarction. | Lancet | 1979 | https://conductscience.org/library/papers/92668 | PubMed |
| 14 | 7,398,002 | Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. | Circulation | 1980 | https://conductscience.org/library/papers/7398002 | PubMed |
| 15 | 372,240 | Platelet and blood vessel arachidonate metabolism and interactions. | J Clin Invest | 1979 | https://conductscience.org/library/papers/372240 | PubMed |
| 16 | 324,036 | Controlled trial of aspirin in cerebral ischemia. | Stroke | 1977 | https://conductscience.org/library/papers/324036 | PubMed |
| 17 | 483,232 | Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study. | Thromb Haemost | 1979 | https://conductscience.org/library/papers/483232 | PubMed |
| 18 | 6,135,989 | Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6135989 | PubMed |
| 19 | 795,299 | Are agents affecting platelet functions clinically useful? | Am J Med | 1976 | https://conductscience.org/library/papers/795299 | PubMed |
| 20 | 4,593,555 | A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. | Br Med J | 1974 | https://conductscience.org/library/papers/4593555 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3,125,883 | Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration. | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/3125883 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6745127
GET https://conductscience.org/api/papers/v1/6745127/references?page=2